Skip to main content
. 2014 Jan 30;9(1):e86941. doi: 10.1371/journal.pone.0086941

Table 9. Objective Response to Neoadjuvant Chemotherapy.

Authors n CR+PR SD+PD
Shchepotin et al [41] 47 41 (87.1%) 6 (12.9%)
Hartgrink et al [45] 25 8 (32%) 17 (68%); 10 SD+7 PD
Nio et al [46] 87 29 (33.3%); 2 CR+27 PR 58 (66.7%); 58 CR+0 PD
Imano et al [48] 16 1 (6.25%); 0 CR+1 PR 15 (93.75%); 15 SD+0 PD
Schuhmacher et al [49] 69 26 (37.68%); 5 CR+21 PR 43 (62.32%); 39 SD+4 PD

CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease.